Stemgenics
Stemgenics is a pioneering biotech company specializing in nanotherapeutics for in vivo cell reprogramming. Their innovative platform utilizes patent-protected multi-functionalized nanoparticles (NIMFA-NP) to deliver therapeutics for regenerative medicine, oncology, vaccine development, and antiviral therapies. With a focus on safe, effective, and off-the-shelf regenerative solutions, Stemgenics aims to revolutionize treatment approaches by enabling direct cell reprogramming without the use of viruses or DNA, preserving genomic integrity and offering broad therapeutic applications.
Industries
Nr. of Employees
small (1-50)
Patents
Functionalized nanoparticles for intracellular delivery of biologically active molecules
US-9675708-B2
View Details
Functionalized nanoparticles for intracellular delivery of biologically active molecules
US-9675708-B2
View DetailsProducts
Multi-functionalized nanoparticle therapeutic platform
A nanoparticle-based therapeutic platform capable of delivering combinations of mRNA, siRNA, proteins, peptides and small molecules to cytoplasm and nucleus for reprogramming, vaccine, antiviral, and oncology applications.
Multi-functionalized nanoparticle therapeutic platform
A nanoparticle-based therapeutic platform capable of delivering combinations of mRNA, siRNA, proteins, peptides and small molecules to cytoplasm and nucleus for reprogramming, vaccine, antiviral, and oncology applications.
Services
A multi-functionalized nanoparticle platform designed for in vivo reprogramming of somatic cells and delivery of RNA and other bioactive cargos for therapeutic development and preclinical use.
Functionalization of biodegradable nanoparticles with user-defined combinations of mRNA, siRNA, proteins, peptides, and small molecules to modulate gene expression or reprogram cell fate.
A multi-functionalized nanoparticle platform designed for in vivo reprogramming of somatic cells and delivery of RNA and other bioactive cargos for therapeutic development and preclinical use.
Functionalization of biodegradable nanoparticles with user-defined combinations of mRNA, siRNA, proteins, peptides, and small molecules to modulate gene expression or reprogram cell fate.
Expertise Areas
- Cellular reprogramming and regenerative medicine
- Nanotherapeutics platform development
- mRNA and siRNA therapeutic delivery
- Oncology therapeutic modulation via RNA-based approaches
Key Technologies
- Non-integrating multi-functionalized nanoparticles
- mRNA synthesis and modification
- siRNA delivery
- Cytoplasmic and nuclear targeting elements